STOCK TITAN

DELPHX ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
private placement

DelphX Capital Markets (OTCQB: DPXCF) announced a non-brokered private placement of up to 3,750,000 Units at C$0.04 per Unit to raise up to C$150,000 in gross proceeds. Each Unit comprises one common share and one warrant exercisable at C$0.08 for two years.

The Offering is subject to TSX Venture Exchange approval, securities will carry a four-month-plus-one-day hold period, finder's fees may be paid, insiders may participate subject to insider trading policy, and net proceeds are intended for general corporate purposes.

Loading...
Loading translation...

Positive

  • Raises up to C$150,000 in gross proceeds
  • Each Unit includes a warrant exercisable at C$0.08 for two years
  • Offering allows insider participation subject to policy

Negative

  • Issuance of up to 3,750,000 Units will dilute existing shareholders
  • Finder's fees may increase effective dilution or reduce net proceeds
  • Offering requires TSX Venture Exchange approval before completion

Toronto, ON, April 22, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of up to 3,750,000 units (the "Units") at a subscription price of C$0.04 per Unit, for gross proceeds of up to C$150,000. Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of C$0.08, for a period of two years from the date of issuance.

In connection with the Offering, DelphX may elect to pay finder's fees to eligible finders, and details of any finder’s fees paid will be announced at a later date.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance. DelphX insiders may participate in the Offering, subject to compliance with DelphX's insider trading policy.

DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

  • Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
  • Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com

(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


FAQ

What are the key terms of DelphX's (DPXCF) April 22, 2026 private placement?

Direct answer: DelphX is offering up to 3,750,000 Units at C$0.04 each, for gross proceeds up to C$150,000. According to the company, each Unit includes one common share and one warrant exercisable at C$0.08 for two years from issuance.

How will the warrants in DelphX's (DPXCF) offering work and when do they expire?

Direct answer: Each warrant permits purchase of one common share at C$0.08 and expires two years after issuance. According to the company, warrant exercise price and two-year term apply from the date of issuance for holders who receive Units.

Can DelphX insiders participate in the DPXCF private placement?

Direct answer: Yes, DelphX insiders may participate, subject to the company's insider trading policy. According to the company, any insider participation must comply with that policy and applicable regulatory rules before completion of the Offering.

What approvals and restrictions apply to DelphX's (DPXCF) private placement?

Direct answer: Completion is subject to TSX Venture Exchange approval, and securities will be subject to a four-month-plus-one-day hold period. According to the company, regulatory approval and the statutory hold period apply to issued securities.

How does DelphX (DPXCF) plan to use the proceeds from the private placement?

Direct answer: DelphX intends to use net proceeds for general corporate purposes. According to the company, the funds raised from the Offering are earmarked for general corporate needs rather than a specified project or acquisition.